Citations

Clear

55 citation(s) found for "Sengupta, S".

Rare Expression of KIT and Absence of KIT Mutations in High Grade Renal Cell Carcinoma
Sengupta, Shomik , Cheville, John C. , Corless, Christopher L. , Lohse, Christine M. , Heinrich, Michael C. , Kwon, Eugene D., Zincke, Horst, Blute, Michael L., Leibovich, Bradley C. , Heinrich, Michael C

Mayo Clinic

Journal of Urology | December 22, 2005 | Volume: 175 | Issue: 1 | Pages: 53-56

10.1016/s0022-5347(05)00059-5 | PMID 16406868 Get It

PREOPERATIVE PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AND VELOCITY ARE STRONG AND INDEPENDENT PREDICTORS OF OUTCOMES FOLLOWING RADICAL PROSTATECTOMY
Sengupta, Shomik , Myers, Robert P., Slezak, Jeffrey M., Bergstralh, Eric J., Zincke, Horst, Blute, Michael L.

Mayo Clinic

Journal of Urology | November 3, 2005 | Volume: 174 | Issue: 6 | Pages: 2191-2196

10.1097/01.ju.0000181209.37013.99 | PMID 16280762 Get It

RE: THE ACCURACY OF 250 FINE NEEDLE BIOPSIES OF RENAL TUMORS
Sengupta, Shomik , Zincke, Horst, Blute, Michael L.

Mayo Clinic

Journal of Urology | November 3, 2005 | Volume: 174 | Issue: 6 | Pages: 2422-2422

10.1097/01.ju.0000180498.58170.e6 | PMID 16280865 Get It

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
Thompson, R. Houston , Gillett, Michael D., Cheville, John C. , Lohse, Christine M. , Dong, Haidong , Webster, W. Scott, Krejci, Kent G., Lobo, John R., Sengupta, Shomik , Zincke, Horst, Blute, Michael L., Strome, Scott E. , Leibovich, Bradley C. , Kwon, Eugene D., Chen, Lieping , Dong, Haidong

Mayo Clinic

Proceedings of the National Academy of Sciences | November 29, 2004 | Volume: 101 | Issue: 49 | Pages: 17174-17179

10.1073/pnas.0406351101 | PMID 15569934 Get It

Expression of B7-H1, a costimulating glycoprotein in the B7 family, is normally restricted to macrophage-lineage cells, providing a potential costimulatory signal source for regulation of T cell activation. In contrast, aberrant expression of B7-H1 by tumor cells has been implicated in impairment of T cell function and survival, resulting in defective host antitumoral immunity. The relationship between tumor-associated B7-H1 and clinical cancer progression is unknown. Herein, we report B7-H1 expression by both renal cell carcinoma (RCC) tumors of the kidney and RCC tumor-infiltrating lymphocytes. In addition, our analysis of 196 clinical specimens reveals that patients harboring high intratumoral expression levels of B7-H1, contributed by tumor cells alone, lymphocytes alone, or tumor and/or lymphocytes combined, exhibit aggressive tumors and are at markedly increased risk of death from RCC. In fact, patients with high tumor and/or lymphocyte B7-H1 levels are 4.5 times more likely to die from their cancer than patients exhibiting low levels of B7-H1 expression (risk ratio 4.53; 95% confidence interval 1.94–10.56; P < 0.001.) Thus, our study suggests a previously undescribed mechanism whereby RCC may impair host immunity to foster tumor progression. B7-H1 may prove useful as a prognostic variable for RCC patients both pre- and posttreatment. In addition, B7-H1 may represent a promising target to facilitate more favorable responses in patients who require immunotherapy for treatment of advanced RCC.
Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest
Sengupta, Sagar , Robles, Ana I. , Linke, Steven P. , Sinogeeva, Natasha I., Pedeux, Rémy , Ward, Irene M., Celeste, Arkady, Nussenzweig, André , Halazonetis, Thanos D. , Harris, Curtis C. , Zhang, Ran , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | September 13, 2004 | Volume: 166 | Issue: 6 | Pages: 801-813

10.1083/jcb.200405128 | PMID 15364958 Get It

Bloom's syndrome is a rare autosomal recessive genetic disorder characterized by chromosomal aberrations, genetic instability, and cancer predisposition, all of which may be the result of abnormal signal transduction during DNA damage recognition. Here, we show that BLM is an intermediate responder to stalled DNA replication forks. BLM colocalized and physically interacted with the DNA damage response proteins 53BP1 and H2AX. Although BLM facilitated physical interaction between p53 and 53BP1, 53BP1 was required for efficient accumulation of both BLM and p53 at the sites of stalled replication. The accumulation of BLM/53BP1 foci and the physical interaction between them was independent of γ-H2AX. The active Chk1 kinase was essential for both the accurate focal colocalization of 53BP1 with BLM and the consequent stabilization of BLM. Once the ATR/Chk1- and 53BP1-mediated signal from replicational stress is received, BLM functions in multiple downstream repair processes, thereby fulfilling its role as a caretaker tumor suppressor.